This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Profiting From Panic

Cramer said that while he's not yet sounding the alarm, Sebastian's work indicates investors cannot afford to be complacent. After each of the previous market declines, there were buying opportunities.

But given how fast those declines happened, there may not be time to sell and buy back in, so staying the course may still be a valid strategy.

Lightning Round

In the Lightning Round, Cramer was bullish on Rentech Nitrogen (RNF), CVR Refining (CVRR), Bank of New York Mellon (BK), Google (GOOG) and Opko Health (OPK).

Cramer was bearish on CVR Energy (CVI), Apollo Residential Mortgage (AMTG), Yandex (YNDX) and Yamana Gold (AUY).

Executive Decision: Tarek Sherif

In his second "Executive Decision" segment, Cramer sat down with Tarek Sherif, chairman and CEO of Medidata Solutions (MDSO - Get Report), a cloud computing company focused on helping biotech firms with their clinical trials. Shares of Medidata are up 74% so far in 2013.

Sherif said Medidata is a leader in the vertical cloud space and is helping more than 350 customers run their clinical trials better and more cost effectively. But the company is just scratching the surface, he said -- there are thousands of companies currently running clinical trials using legacy on-premise technology. By using Medidata, Sherif said, companies can cut costs, get to market faster an reduce risk all at the same time.

Medidata has been innovating for over a decade, said Sherif, and now more than ever companies need faster, more flexible software as many of the new, targeted therapies and drugs demand that quality of data in order to succeed. That's why Medidata works with big names like Abbott Laboratories (ABT) and Amgen (AMGN), along with hundreds of smaller companies.

Cramer said he's been remiss in not mentioning Medidata earlier and likes the company's growth trajectory.

No Huddle Offense

In his "No Huddle Offense" segment, Cramer reminded viewers that leadership is everything. When a company loses a great leader, it may be time to head for the exits.

That's certainly the case with Lululemon Athletica (LULU - Get Report), whose CEO, Christine Day, abruptly announced her resignation.

Cramer said time after time Day proved the skeptics wrong and turned Lulu from a cult yoga brand into a mainstream sports apparel franchise that could one day challenge Nike (NIKE) for dominance.

But without Day at the helm, Cramer said investors are just left with a high-multiple stock, one with a questionable future. That's why he told viewers that on any bounce, it's time to ring the register.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LULU $65.55 0.00%
MDSO $43.63 0.00%
SE $31.27 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs